ES2064341T3 - Nuevas n-(3-hidroxi-4-piperidinil)benzamidas sustituidas. - Google Patents

Nuevas n-(3-hidroxi-4-piperidinil)benzamidas sustituidas.

Info

Publication number
ES2064341T3
ES2064341T3 ES88201400T ES88201400T ES2064341T3 ES 2064341 T3 ES2064341 T3 ES 2064341T3 ES 88201400 T ES88201400 T ES 88201400T ES 88201400 T ES88201400 T ES 88201400T ES 2064341 T3 ES2064341 T3 ES 2064341T3
Authority
ES
Spain
Prior art keywords
piperidinyl
hydroxy
replaced
benzamides
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88201400T
Other languages
English (en)
Inventor
Daele Georges H P Van
Freddy F Vlaeminck
Loon Karel J Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2064341T3 publication Critical patent/ES2064341T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

NUEVAS BENZAMIDAS N-(3-HIDROXI-4-PIPERIDINIL) SUSTITUIDAS DE FORMULA (I) EN LA QUE LOS SUSTITUYENTES TIENEN EL SIGNIFICADO DADO EN LA INVENCION. ESTOS COMPUESTOS SON AGENTES QUE ESTIMULAN LA MOTILIDAD GASTROINTESTINAL. SE INCLUYEN COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS COMO INGREDIENTE ACTIVO Y METODOS PARA PREPARAR LOS COMPUESTOS Y LAS COMPOSICIONES.
ES88201400T 1987-07-17 1988-07-05 Nuevas n-(3-hidroxi-4-piperidinil)benzamidas sustituidas. Expired - Lifetime ES2064341T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7484587A 1987-07-17 1987-07-17

Publications (1)

Publication Number Publication Date
ES2064341T3 true ES2064341T3 (es) 1995-02-01

Family

ID=22122023

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88201400T Expired - Lifetime ES2064341T3 (es) 1987-07-17 1988-07-05 Nuevas n-(3-hidroxi-4-piperidinil)benzamidas sustituidas.

Country Status (23)

Country Link
EP (1) EP0299566B1 (es)
JP (1) JP2642955B2 (es)
KR (1) KR970011156B1 (es)
CN (1) CN1020900C (es)
AT (1) ATE111098T1 (es)
AU (1) AU608338B2 (es)
BG (1) BG48809A3 (es)
CA (1) CA1317951C (es)
DE (1) DE3851388T2 (es)
DK (1) DK396088A (es)
ES (1) ES2064341T3 (es)
FI (1) FI94049C (es)
HU (1) HU201926B (es)
IE (1) IE64469B1 (es)
IL (1) IL87129A (es)
MA (1) MA21327A1 (es)
NO (1) NO171366C (es)
NZ (1) NZ225152A (es)
PH (1) PH25531A (es)
PT (1) PT87990B (es)
SU (1) SU1738088A3 (es)
TN (1) TNSN88073A1 (es)
ZA (1) ZA885151B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JP2524420B2 (ja) * 1990-05-16 1996-08-14 明治製菓株式会社 ピペリジン誘導体及びそれらを有効成分とする抗潰瘍剤
US5082847A (en) * 1990-07-18 1992-01-21 Syntex (U.S.A.) Inc. Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
US6096761A (en) * 1996-02-15 2000-08-01 Janssen Pharmaceutica N.V. Esters of 3-hydroxy-piperidinemethanol derivatives
NZ330263A (en) * 1996-02-15 1999-06-29 Janssen Pharmaceutica Nv Esters of 3-hydroxy-piperidinemethanol derivatives to improve gastric emptying
TW402591B (en) 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
HUP0003078A3 (en) * 1997-07-11 2002-02-28 Janssen Pharmaceutica Nv (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
TW570920B (en) * 1998-12-22 2004-01-11 Janssen Pharmaceutica Nv 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
RU2277092C2 (ru) * 2000-09-15 2006-05-27 Анормед, Инк. Гетероциклические соединения, их применение и фармацевтическая композиция для лечения состояний, опосредованных схсr4 и ccr5
CA2551686C (en) * 2004-01-07 2014-09-23 Ian Irwin Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
EP1799671A4 (en) * 2004-09-02 2009-06-10 Smithkline Beecham Corp CHEMICAL COMPOUNDS
KR100976063B1 (ko) * 2007-03-16 2010-08-17 동아제약주식회사 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법
CN110950843B (zh) * 2019-11-28 2022-12-27 广东东阳光药业有限公司 取代的苯酰胺衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
ZW12187A1 (en) * 1986-07-03 1989-02-01 Janssen Pharmaceutica Nv 4-(aroylamino)piperidinebutanamide derivatives
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides

Also Published As

Publication number Publication date
KR970011156B1 (ko) 1997-07-07
NO883171L (no) 1989-01-18
DE3851388D1 (de) 1994-10-13
MA21327A1 (fr) 1989-04-01
SU1738088A3 (ru) 1992-05-30
DE3851388T2 (de) 1995-01-19
DK396088D0 (da) 1988-07-15
PT87990A (pt) 1989-06-30
CA1317951C (en) 1993-05-18
PH25531A (en) 1991-07-24
EP0299566B1 (en) 1994-09-07
JPS6445382A (en) 1989-02-17
IL87129A0 (en) 1988-12-30
AU1906788A (en) 1989-01-19
KR890002108A (ko) 1989-04-08
AU608338B2 (en) 1991-03-28
NO883171D0 (no) 1988-07-15
NO171366C (no) 1993-03-03
FI94049C (fi) 1995-07-10
ZA885151B (en) 1990-03-28
EP0299566A2 (en) 1989-01-18
FI94049B (fi) 1995-03-31
CN1020900C (zh) 1993-05-26
NO171366B (no) 1992-11-23
HUT49345A (en) 1989-09-28
BG48809A3 (bg) 1991-05-15
IL87129A (en) 1993-03-15
EP0299566A3 (en) 1990-08-08
ATE111098T1 (de) 1994-09-15
DK396088A (da) 1989-01-18
JP2642955B2 (ja) 1997-08-20
NZ225152A (en) 1990-04-26
HU201926B (en) 1991-01-28
CN1030753A (zh) 1989-02-01
FI883378A7 (fi) 1989-01-18
IE882170L (en) 1989-01-17
IE64469B1 (en) 1995-08-09
TNSN88073A1 (fr) 1990-07-10
FI883378A0 (fi) 1988-07-15
PT87990B (pt) 1995-03-01

Similar Documents

Publication Publication Date Title
GT199700095A (es) Derivados 6,5-heterobiciclicos sustituidos.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2084944T3 (es) Amidas terapeuticas.
ES2007318A4 (es) Compuestos de imidazol y composiciones biocidas que los comprenden.
ES2158814B1 (es) Derivados de pirrolidina antagonistas del receptor ccr-3
GT199800046A (es) Compuestos de pirazina.
AR032136A1 (es) Compuestos espiroheterociclicos utiles como inhibidores reversibles de cisteina-proteasas
GT199700015A (es) Inhibidores de metaloproteinasa, composiciones farmaceuticas que las contienen y su uso farmaceutico y metodosyeficazproducto intermedio para su preparacion.
AR001332A1 (es) Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen.
GT199700079A (es) Derivados triciclos sustituidos con fenilamino
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
ES2063011T3 (es) Agentes antibacteriales de quinolonas y naftiridinas que contienen un alfa-aminoacido en la cadena lateral del 7-sustituyente.
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
SV2004001548A (es) Difenilazetidinonas sustituidas en grupo acido, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
ES2088388T3 (es) Composiciones de macrolido para el tratamiento de trastornos de movilidad gastrointestinal.
ES2033985T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica.
DK529888A (da) Substituerede n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamider
AR004158A1 (es) Compuesto de ftalizin-pirido dionas; composición farmacéutica que lo contiene; y proceso para la preparación de dicho compuesto.
ES2167021T3 (es) Derivados de acido 4-bifenil-4-hidroxibutirico sustituidos como inhibidores de metaloproteasa de matriz.
ES2072263T3 (es) Derivados de 4-aminopiridina.
ES2148458T3 (es) Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR045156A1 (es) Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos
MX9400070A (es) Compuestos heterociclicos, un procedimiento para prepararlos, su uso y composiciones farmaceuticas que los contienen.
ES2046193T3 (es) Un procedimiento para la preparacion de un compuesto de imidazolidinona.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 299566

Country of ref document: ES